CLINICAL_TRIALS
research
· 2024-04-26
Clinical Trial Update: Efficacy and Safety of MTBF Conditioning Regimen for Salvageable Allo-HSCT in the Treatment of R/R AML [NA]
Summary
This document reports on a clinical trial evaluating the MTBF conditioning regimen for salvageable allogeneic hematopoietic stem cell transplantation in relapse…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: Relapse Leukemia, Refractory Acute Myeloid Leukemia | NA | Status: NOT_YET_RECRUITING